Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.

Coronavirus immunity infection inflammation mast cell

Journal

Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253

Informations de publication

Date de publication:
Historique:
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 6 2 2020
Statut: ppublish

Résumé

Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals, especially in China. Coronavirus is interspecies and can also be transmitted from man to man, with an incubation ranging from 1 to 14 days. Human coronavirus infections can induce not only mild to severe respiratory diseases, but also inflammation, high fever, cough, acute respiratory tract infection and dysfunction of internal organs that may lead to death. Coronavirus infection (regardless of the various types of corona virus) is primarily attacked by immune cells including mast cells (MCs), which are located in the submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms. Viral activate MCs release early inflammatory chemical copounds including histamine and protease; while late activation provoke the generation of pro-inflammatory IL-1 family members including IL-1, IL-6 and IL-33. Here, we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL-1 family members.

Identifiants

pubmed: 32013309
doi: 10.23812/20-Editorial-Kritas
pii: 33
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-14

Informations de copyright

Copyright 2019 Biolife Sas. www.biolifesas.org.

Auteurs

S K Kritas (SK)

Department of Microbiology and Infectious Diseases, School of Veterinary Medicine, Aristotle University of Thessaloniki, Macedonia, Greece.

G Ronconi (G)

Clinica dei Pazienti del Territorio, Fondazione Policlinico Gemelli, Rome, Italy.

Al Caraffa (A)

School of Pharmacy, University of Camerino, Camerino, Italy.

C E Gallenga (CE)

Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, Ferrara, Italy.

R Ross (R)

University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.

P Conti (P)

Postgraduate Medical School, University of Chieti, Chieti, Italy.

Classifications MeSH